360 related articles for article (PubMed ID: 29478250)
1. High prevalence of hypogonadism determined by serum free testosterone level in Japanese testicular cancer survivors.
Kurobe M; Kawai K; Suetomi T; Iwamoto T; Waku N; Kawahara T; Kojima T; Joraku A; Miyazaki J; Nishiyama H
Int J Urol; 2018 May; 25(5):457-462. PubMed ID: 29478250
[TBL] [Abstract][Full Text] [Related]
2. Androgen deficiency symptoms in testicular cancer survivors are associated with sexual problems but not with serum testosterone or therapy.
Lackner JE; Koller A; Schatzl G; Marberger M; Kratzik C
Urology; 2009 Oct; 74(4):825-9. PubMed ID: 19589582
[TBL] [Abstract][Full Text] [Related]
3. Hypogonadism and androgen deficiency symptoms in testicular cancer survivors.
Lackner JE; Märk I; Schatzl G; Marberger M; Kratzik C
Urology; 2007 Apr; 69(4):754-8. PubMed ID: 17445664
[TBL] [Abstract][Full Text] [Related]
4. The effects of hypogonadism on quality of life in survivors of germ cell tumors treated with surgery alone versus surgery plus platinum-based chemotherapy.
Khanal N; Ahmed SS; Kalra M; Miller TJ; Brames MJ; Stump TE; Monahan P; Hanna NH; Einhorn LH
Support Care Cancer; 2020 Jul; 28(7):3165-3170. PubMed ID: 31707501
[TBL] [Abstract][Full Text] [Related]
5. Association among hypogonadism, quality of life and erectile dysfunction in middle-aged and aged male in Taiwan.
Hwang TI; Lo HC; Tsai TF; Chiou HY
Int J Impot Res; 2007; 19(1):69-75. PubMed ID: 16688209
[TBL] [Abstract][Full Text] [Related]
6. Testosterone levels in men with erectile dysfunction.
Martínez-Jabaloyas JM; Queipo-Zaragozá A; Pastor-Hernández F; Gil-Salom M; Chuan-Nuez P
BJU Int; 2006 Jun; 97(6):1278-83. PubMed ID: 16686726
[TBL] [Abstract][Full Text] [Related]
7. Quality of Life in Long-Term Testicular Cancer Survivors With Compensated Leydig Cell Dysfunction.
Skøtt JW; Lauritsen J; Kreiberg M; Daugaard G; Bandak M
Clin Genitourin Cancer; 2019 Feb; 17(1):e65-e71. PubMed ID: 30293923
[TBL] [Abstract][Full Text] [Related]
8. Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study.
O'Carrigan B; Fournier M; Olver IN; Stockler MR; Whitford H; Toner GC; Thomson DB; Davis ID; Hanning F; Singhal N; Underhill C; Clingan P; McDonald A; Boland A; Grimison P;
Intern Med J; 2014 Aug; 44(8):813-7. PubMed ID: 25081047
[TBL] [Abstract][Full Text] [Related]
9. Can testosterone level be a good predictor of late-onset hypogonadism?
Heidari R; Sajadi H; Pourmand A; Pourmand G
Andrologia; 2015 May; 47(4):433-7. PubMed ID: 24773173
[TBL] [Abstract][Full Text] [Related]
10. Erectile dysfunction in men treated for testicular cancer.
Tal R; Stember DS; Logmanieh N; Narus J; Mulhall JP
BJU Int; 2014 Jun; 113(6):907-10. PubMed ID: 24053222
[TBL] [Abstract][Full Text] [Related]
11. Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism.
Almehmadi Y; Yassin DJ; Yassin AA
Aging Male; 2015; 18(3):186-94. PubMed ID: 26030350
[TBL] [Abstract][Full Text] [Related]
12. Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism.
Okada K; Miyake H; Ishida T; Sumii K; Enatsu N; Chiba K; Matsushita K; Fujisawa M
Am J Mens Health; 2018 Sep; 12(5):1403-1408. PubMed ID: 27256990
[TBL] [Abstract][Full Text] [Related]
13. Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors.
Sprauten M; Haugnes HS; Brydøy M; Kiserud C; Tandstad T; Bjøro T; Bjerner J; Cvancarova M; Fosså SD; Oldenburg J
Ann Oncol; 2015 Oct; 26(10):2133-40. PubMed ID: 26265167
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of nasal continuous positive airway pressure on patients with OSA with erectile dysfunction and low sex hormone levels.
Li Z; Tang T; Wu W; Gu L; Du J; Zhao T; Zhou X; Wu H; Qin G
Respir Med; 2016 Oct; 119():130-134. PubMed ID: 27692134
[TBL] [Abstract][Full Text] [Related]
15. Treatment of testicular cancer: influence on pituitary-gonadal axis and sexual function.
Lackner J; Schatzl G; Koller A; Mazal P; Waldhoer T; Marberger M; Kratzik C
Urology; 2005 Aug; 66(2):402-6. PubMed ID: 16040104
[TBL] [Abstract][Full Text] [Related]
16. Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothers.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Andrology; 2017 Jul; 5(4):718-724. PubMed ID: 28598554
[TBL] [Abstract][Full Text] [Related]
17. Sexual function in men treated for testicular cancer.
Eberhard J; Ståhl O; Cohn-Cedermark G; Cavallin-Ståhl E; Giwercman Y; Rylander L; Eberhard-Gran M; Kvist U; Fugl-Meyer KS; Giwercman A
J Sex Med; 2009 Jul; 6(7):1979-89. PubMed ID: 19453896
[TBL] [Abstract][Full Text] [Related]
18. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
[TBL] [Abstract][Full Text] [Related]
19. Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors.
Ekedahl H; Isaksson S; Ståhl O; Bogefors K; Romerius P; Eberhard J; Giwercman A
BMC Cancer; 2022 Feb; 22(1):157. PubMed ID: 35135482
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β-hCG and cancer treatment.
Steggink LC; van Beek AP; Boer H; Meijer C; Lubberts S; Oosting SF; de Jong IJ; van Ginkel RJ; Lefrandt JD; Gietema JA; Nuver J
Andrology; 2019 Jul; 7(4):441-448. PubMed ID: 30609309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
